U n i v e r s a l D r u g C o m p l i a n c e
A PERENNIAL PROBLEM
Poor drug adherance is estimated to cost the global health industry $300 billion + every year.
In the UK this is estimated to cost the NHS alone £1 billion annually
Despite many interventions, levels of patient compliance have remained almost unchanged for 3 decades.
The problem is that most compliance programs still focus on specific targets and only ever scratch the surface - so they
never acheive the critical mass needed to tackle the underlying culture of non-compliance across the population.
Even the launch of digital media has had very little impact on these figures, and very much like the internet of
a decade before, still tend to isolate the very groups we all need to target the most.
The global financial crisis - and the austerity measures that followed - also mean that solving this perennial
problem has now become a top priority for most healthcare systems across the globe.
Any solution, therefore, requires a completely new approach - and some lateral thinking.
The Universal Drug Compliance Program